There are specific circumstances in which you should seek prompt medical advice, either from your trial team or your GP: Persistent insomnia lasting more than three to four weeks that is significantly affecting your daytime functioning, mood, or concentration Symptoms of anxiety or low mood that have developed or worsened since starting treatment, as these can both cause and be exacerbated by poor sleep Signs of obstructive sleep apnoea such as loud snoring, gasping during sleep (reported by a partner), or excessive daytime sleepiness which require formal assessment and may need referral to a sleep clinic New or worsening palpitations or an irregular heartbeat at night GLP-1-based medicines can be associated with a modest increase in resting heart rate
Why GLP-1 Agonists May Increase Kidney Stone Risk The primary mechanism linking GLP-1 agonists to kidney stones is dehydration
It says limited prospective studies directly compare antibiotic efficacy in semaglutide-treated versus untreated populations, and that most safety data come from case reports and pharmacokinetic modeling
The Precision Peptide Genetic Test analyzes your GIPR, FTO, and MC4R variants across 14 metabolic pathways to confirm your body's responsiveness to semaglutide
As an arts administrator, she has worked at Shakespeare Theater Company, Victory Gardens Theater, Hudson Scenic Studio, and has taught across the country with The Acting Company